NantHealth, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 22, 2023 at 06:14 am EDT
Share
NantHealth, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 17.26 million compared to USD 16.5 million a year ago. Net loss was USD 17.49 million compared to USD 12.51 million a year ago. Basic loss per share from continuing operations was USD 2.27 compared to USD 1.62 a year ago.
For the six months, revenue was USD 34.31 million compared to USD 32.87 million a year ago. Net loss was USD 29.73 million compared to USD 28.46 million a year ago. Basic loss per share from continuing operations was USD 3.86 compared to USD 3.7 a year ago.
NantHealth, Inc. provides enterprise solutions that help businesses transform complex data into actionable insights. The Company is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it secure and scalable. The Companyâs products include Eviti Connect and Eviti Advisor, NaviNet, NaviNet Open, NaviNet AllPayer, OpenNMS, and Quadris. Its product portfolio comprises the technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet) and data solutions that include multi-data analysis, reporting, and professional service offerings (Quadris). In addition, The OpenNMS Group, Inc. (OpenNMS), a Companyâs subsidiary, helps businesses monitor and manage network health and performance.
NANTHEALTH, INC. 
